Developing more personalized medicine in patients with relapsing-remitting multiple sclerosis (RRMS) can lead to the development of a modelling strategy that detects and validates an Individual treatment response (ITR) score and opens avenues for building treatment response calculators that are also applicable in routine clinical practice.
Why this matters
Attempts have been made recently to apply personalized medicine to patients with MS but were unable to disentangle the prognostic role of baseline covariates from their role as treatment effect modifiers and this proof-of-concept analysis may lead to the creation of a treatment algorithm that provide improved support in treatment decisions for MS patients by neurologists.
Möchten Sie mehr lesen?
Loggen Sie sich ein oder registrieren Sie sich, um Zugang zu allen Inhalten von Neurodiem zu erhalten.
Sie haben bereits einen Account? Einloggen
International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.